Chemomab Earns New Patents for CM-101, Pioneering Monoclonal Antibody in Clinical Development for Fibro-Inflammatory Diseases.
Biotech Company Secures New Patent For Fibro-inflammatory Disease Treatment Candidate
Biotech Company Secures New Patent For…
Biotech Company Secures New Patent For Fibro-inflammatory Disease Treatment Candidate
Chemomab Earns New Patents for CM-101, Pioneering Monoclonal Antibody in Clinical Development for Fibro-Inflammatory Diseases.